Published: 2022-10-26

Association of anemia and hypoalbuminemia with mortality among patients undergoing routine hemodialysis

Yuliana Hioe, Maria D. Bria, Maria Teressa, David Santosa


Background: The progressivity of chronic kidney disease (CKD) is associated with several clinical conditions which contribute to high morbidity and mortality, including anemia and hypoalbuminemia. This study aimed to assess the association of anemia and hypoalbuminemia with the mortality of CKD patients undergoing routine hemodialysis (HD) in Siloam Hospital Kupang.

Methods: We conducted a retrospective cohort study based on Indonesia renal registry data system and hospital medical records. We studied the following variables: gender, age, etiology of CKD, vascular access of HD, and prevalence of anemia and hypoalbuminemia. All analysis was performed using SPSS software version 22.

Results: There were 128 patients enrolled in this study. Of the total patients who died, most of them died within the first 3 months since the initiation of HD (62.1%). The majority of patients had anemia (67.2%) and hypoalbuminemia (69.5%). The bivariate analysis showed that anemia (p value=0.192), and hypoalbuminemia (p value=0.336) were not statistically significant associated with mortality among patients undergoing routine HD.

Conclusions: Anemia and hypoalbuminemia are not statistically associated with mortality outcome of CKD patients in Siloam Hospital Kupang. However, these conditions may still have prognostic importance for CKD patients undergoing routine HD. Further studies with larger size of cohort and longer period of time are warranted.


Anemia, Hemodialysis, Hypoalbuminemia, Mortality, Chronic kidney disease

Full Text:



Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709-33.

Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567-81.

Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int. 2017;7(2):122-29.

Umami V, Lydia A, Nainggolan G, Setiati S. Pengembangan model prediksi mortalitas 3 bulan pertama pada pasien penyakit ginjal kronik yang menjalani hemodialisis. J Penyakit Dalam Indo. 2017; 2(3):170-82.

Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM. Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int. 2000;57(6):2539-45.

Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM. Early outcomes among those initiating chronic dialysis in the united states. Clin J Am Soc Nephrol. 2011;6(11): 2642-9.

Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJG, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67(3):1038-46.

KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006; 47(3):S11-145.

Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med. 2006; 119(4):327-34.

Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol. 1997;8(12):1921-9.

Shrestha T, Bhusal L, Neupane R, Ghimire R, Prasad P. Risk factors associated with mortality among chronic kidney disease patients on regular hemodialysis presenting in emergency services. J Biomed Res Environ Sci. 2021;2(1):1-7.

Karaboyas A, Morgenstern H, Waechter S, Fleischer NL, Vanholder R, Jacobson SH, et al. Low hemoglobin at hemodialysis initiation: An international study of anemia management and mortality in the early dialysis period. Clin Kidney J. 2019;5;13(3):425-33.

Haller C. Hypoalbuminemia in renal failure: Pathogenesis and therapeutic considerations. Kidney Blood Press Res. 2006;28(6):307-10.

Schmidt RJ, Pellegrino B, MacKay K, Parravani T, Mustafa R, Hobbs G. Prevalence and predictive value of hypoalbuminemia in appalachians with chronic kidney disease. World J Nephrol Urol. 2012;1(1):8-15.

Port FK, Pisoni RL, Bragg-Gresham JL, Satayathum SS, Young EW, Wolfe RA, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004;22(1):175-80.

Dwyer JT, Larive B, Leung J, Rocco MV, Greene T, Burrowes J, et al. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?. Kidney Int. 2005;68(4):1766-76.

Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2(1):89-99.